Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy Approaches. Int J Radiat Oncol Biol Phys 2026 Jan 01;124(1):190-193
Date
12/15/2025Pubmed ID
41391923Pubmed Central ID
PMC12939519DOI
10.1016/j.ijrobp.2025.08.020Scopus ID
2-s2.0-105024206020 (requires institutional sign-in at Scopus site)Author List
Said I, Awan MJ, Wong SJ, Memon AA, Kearl T, Hematti P, Massey B, Bruening J, Akakpo K, Zenga J, Himburg HAAuthors
Musaddiq J. Awan MD Associate Professor in the Radiation Oncology department at Medical College of WisconsinJennifer D. Bruening MD Assistant Professor in the Otolaryngology and Communication Sciences department at Medical College of Wisconsin
Peiman Hematti MD Professor in the Medicine department at Medical College of Wisconsin
Heather A. Himburg PhD Professor in the Radiation Oncology department at Medical College of Wisconsin
Tyce J. Kearl PhD, MD Assistant Professor in the Medicine department at Medical College of Wisconsin
Becky Massey MD Associate Professor in the Otolaryngology and Communication Sciences department at Medical College of Wisconsin
Abdullah A. Memon Predoctoral Research Scholar in the Cancer Center department at Medical College of Wisconsin
Joseph Zenga MS, MD Chief, Associate Professor in the Otolaryngology and Communication Sciences department at Medical College of Wisconsin
